PT Kimia Farma Tbk : Link Download Revision to the Summons FY 2025 AGMS

REVISION TO THE NOTICE OF GENERAL MEETING OF SHAREHOLDERS OF 2025

PT KIMIA FARMA (PERSERO) Tbk

Referring to the Notice to the Annual General Meeting of Shareholders of PT Kimia Farma (Persero) Tbk ("Company") for Fiscal Year 2025, which was published on the websites of Indonesia Stock Exchange, eASY.KSEI, and PT Kimia Farma (Persero) Tbk on 12 May 2026, the Company hereby informs the shareholders of the Company that in relation to the Annual General Meeting of Shareholders of the Company for Fiscal Year 2025 ("MEETING"), which will be held on Wednesday, 3 June 2026, there is a revision to the wording of the First Agenda Item of the MEETING, which shall read as follows:

"Approval of the Company's Annual Report for Fiscal Year 2025 and ratification of the Company's Consolidated Financial Statements for Fiscal Year 2025, the Supervisory Duties Report of the Board of Commissioners for Fiscal Year 2025, as well as ratification of the Report on the Implementation of the Micro and Small Business Funding Program (PUMK) for Fiscal Year 2025, and the granting of full release and discharge (volledig acquit et de charge) to the Board of Directors for the management actions of the Company and to the Board of Commissioners for the supervisory actions of the Company carried out during Fiscal Year 2025."

With respect to the implementation of the MEETING through electronic General Meetings of Shareholders (e -GMS) as referred to in Financial Services Authority Regulation ("POJK") No. 15/POJK.04/2020 concerning the Planning and Conduct of General Meetings of Shareholders of Public Companies ("POJK No. 15/2020") and POJK No. 14 of 2025 concerning the Electronic Implementation of General Meetings of Shareholders, General Meetings of Bondholders, and General Meetings of Sukuk Holders, the MEETING will be conducted electronically using the e-GMS system provided by Kustodian Sentral Efek Indonesia, namely eASY.KSEI. The Chairperson of the Meeting, the Notary, and the Supporting Professions and Institutions will coordinate for the electronic implementation of the MEETING at Indonesia Health Learning Institute. Jl. Cipinang Cimpedak I No. 36, Jakarta Timur.

Accordingly, following the revision to the wording of the First Agenda Item, the Agenda Items of the MEETING shall be as follows:

.

The MEETING will be conducted with the following agendas:

1. Approval of the Company's Annual Report for Fiscal Year 2025 and ratification of the Company's Consolidated Financial Statements for Fiscal Year 2025, the Supervisory Duties Report of the Board of Commissioners for Fiscal Year 2025, as well as ratification of the Report on the Implementation of the Micro and Small Business Funding Program (PUMK) for Fiscal Year 2025, and the granting of full release and discharge (volledig acquit et de charge) to the Board of Directors for the management actions of the Company and to the Board of Commissioners for the supervisory actions of the Company carried out during Fiscal Year 2025.

   Brief description:

   1. Pursuant to Article 12 paragraph (2) letter b in conjunction with Article 19 and Article 22 paragraph (2) of the Company's Articles of Association, as well as Law Number 40 of 2007 concerning Limited Liability Companies, as amended ("Company Law"), it is stipulated that:

      1. the Board of Directors shall submit the Annual Report to the General Meeting of Shareholders (GMS) after it has been reviewed by the Board of Commissioners;

      2. the approval of the Annual Report, including the ratification of the financial statements and the supervisory duties report of the Board of Commissioners, shall be carried out by the GMS.

   2. Pursuant to Article 33 paragraph (1) of the Regulation of the Minister of State-Owned Enterprises Number PER-1/MBU/03/2023 of 2023 concerning Special Assignments and the Corporate Social and Environmental Responsibility Program of State-Owned Enterprises ("MOE Regulation 01/2023"), the financial statements and the implementation report of the SOE TJSL Program shall form an integral part of the quarterly reports and annual performance reports of SOEs and shall be presented in a separate chapter therein.

2. Determination of the Salary/Honorarium, including Facilities and Allowances for Fiscal Year 2026, as well as Performance-Based Remuneration for Fiscal Year 2025 for the Management of the Company.

   Brief description:

   As previously explained in the Notice published on 12 May 2026.

3. Determination of the Public Accountant and/or Public Accounting Firm to Audit the Company's Consolidated

   Financial Statements and the Financial Statements of the PUMK Program for Fiscal Year 2026.

   Brief description:

   As previously explained in the Notice published on 12 May 2026.

4. Delegation of Authority to Approve the Company's Long-Term Plan (Rencana Jangka Panjang Perusahaan or "RJPP") for the 2026-2030 Period and the Company's Work Plan and Budget (Rencana Kerja dan Anggaran Perusahaan or "RKAP") for Fiscal Year 2027, including any amendments thereto, from the General Meeting of Shareholders ("GMS") to a party designated by the GMS.

   Brief description:

   As previously explained in the Notice published on 12 May 2026.

5. Report on the Implementation of the Conversion of Mandatory Convertible Bonds (Obligasi Wajib Konversi/OWK) into shares in the context of increasing the Company's capital, as well as approval for the granting of authority to the Company's Board of Commissioners to declare the amount of the increase in issued and paid-up capital.

   Brief description:

   As previously explained in the Notice published on 12 May 2026.

6. Report on the Implementation of the Transfer/Disposal and Write-Off of the Company's Assets representing more than 50% of the Company's net assets, as approved in the Extraordinary General Meeting of Shareholders ("EGMS") of the Company dated 3 November 2025.

   Brief description:

   As previously explained in the Notice published on 12 May 2026.

7. Changes in the Composition of the Company's Management.

Brief description:

As previously explained in the Notice published on 12 May 2026.

The date of the Shareholders Register (Recording Date), containing the list of the Company's shareholders entitled to attend the MEETING, as well as all provisions and procedures previously announced in the Invitation, shall remain valid and unchanged.

In accordance with POJK No. 15/2020 and the provisions of the Company's Articles of Association, this Revision to the Notice of the MEETING is published through the Indonesian Stock Exchange's website, eASY.KSEI, and the Company's website.

Thus, this Revision to the Invitation/Notice of the MEETING is conveyed for the attention of the Company's

shareholders.

Jakarta, May 22, 2026

PT Kimia Farma (Persero) Tbk Board of Dvirectors